HSA
WGS icon

Hussman Strategic Advisors’s GeneDx Holdings WGS Stock Holding History

Hussman Strategic Advisors’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,500
Closed -$1.37M – 342
2025
Q4 		$1.37M Sell
10,500
-2,100
-17% -$288K 0.33% 138
2025
Q3 		$1.36M Sell
12,600
-8,400
-40% -$915K 0.29% 155
2025
Q2 		$1.94M Sell
21,000
-10,500
-33% -$824K 0.44% 89
2025
Q1 		$2.79M Buy
+31,500
New +$2.73M 0.68% 35
2024
Q4 		– Sell
-63,000
Closed -$2.67M – 311
2024
Q3 		$2.67M Buy
+63,000
New +$2.13M 0.66% 43

Other funds holding WGS

Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $1.1B AUM 171.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Hussman Strategic Advisors's WGS Position: Q1 2026 in Review

Hussman Strategic Advisors sold out of GeneDx Holdings (WGS) in Q1 2026, closing a stake of 10,500 shares — an estimated $1.37M sold.

Hussman Strategic Advisors first reported a position in WGS in Q3 2024 and held it in 5 quarters. The position peaked at $2.79M in Q1 2025. 241 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Hussman Strategic Advisors reported no remaining GeneDx Holdings position as of Q1 2026 after selling out during the quarter.
  • Hussman Strategic Advisors sold 10,500 GeneDx Holdings shares in Q1 2026, an estimated $1.37M.
  • Hussman Strategic Advisors first reported a position in GeneDx Holdings in Q3 2024 and held it in 5 quarters.
  • Hussman Strategic Advisors's GeneDx Holdings position peaked at $2.79M in Q1 2025.
  • 241 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Hussman Strategic Advisors's 13F filing for Q1 2026, filed 11 May 2026.